10 Year Financial Data of Medicines (MDCO)

35.76 (1y: +69%)

Market Cap	2 B	P/E(ttm)	61.00
Enterprise Value	1.98 B	P/B	3.33

MDCO- NAS (USA)
Medicines

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$35.76

4 Severe Warning Signs 3 Medium Warning Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	20	10.1	17.5
EBITDA Growth (%)	0	0	-4.4
Free Cash Flow Growth (%)	0	44.8	-45.7
Book Value Growth (%)	13.7	21.4	19.8

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	1.88	2.90	3.04	4.19	4.99	6.71	7.73	8.23	8.91	10.09	10.70	2.27	2.44	2.48	2.90	2.88
EBITDA per Share	-0.37	0.35	-0.22	0.21	-0.53	-0.15	-0.37	1.33	1.18	1.63	1.08	0.25	0.39	0.30	0.70	-0.31
Free Cashflow per Share	-0.14	0.25	-0.55	0.61	0.38	0.32	0.01	1.26	1.62	0.16	0.19	-0.93	0.37	0.26	0.46	-0.90
Earnings per Share ($)	-0.37	0.34	-0.16	1.25	-0.35	-0.16	-1.46	1.97	2.35	0.93	0.59	0.14	0.25	0.17	0.38	-0.21
Book Value per Share	3.07	3.45	3.46	5.29	5.38	5.74	4.60	6.72	9.40	10.59	11.33	9.46	9.59	10.13	10.66	11.33
Month End Stock Price	29.46	28.80	17.45	31.72	19.16	14.73	8.34	14.13	18.64	23.97	33.41	20.07	22.94	25.81	23.97	33.41
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	-12.00	9.90	-4.50	23.60	-6.60	-2.90	-31.70	29.30	25.00	8.70	-7.60	5.60	10.40	6.80	14.00	-7.60
Return on Assets %	-10.10	8.10	-3.70	20.00	-5.10	-2.20	-20.30	22.10	18.50	5.30	-4.00	4.40	6.00	4.00	8.40	-4.00
Return on Capital - Joel Greenblatt %	-338	106	-35.50	29.70	--	-61.60	-509	486	1,275	124	-79.20	152	221	146	218	-79.20
Debt to Equity	--	--	--	--	--	--	--	--	--	0.39	0.37	--	0.42	0.40	0.39	0.37

Gross Margin %	73.40	79.80	76.90	75.80	74.20	74.60	70.80	70.50	67.60	68.30	63.60	69.50	68.50	68.00	67.30	63.60
Operating Margin %	-21.20	10.80	-8.00	4.80	-10.90	-3.10	-6.30	14.70	12.00	14.90	-14.50	9.50	14.40	11.00	22.80	-14.50
Net Margin %	-19.70	11.80	-5.20	29.80	-7.10	-2.40	-18.90	23.90	26.40	9.20	-7.40	6.00	10.10	6.80	13.00	-7.40

Days Sales Outstanding	71.00	48.80	37.70	39.10	38.50	36.70	27.70	39.90	56.40	56.40	52.90	48.80	44.20	55.80	49.20	52.90
Days Inventory	184	343	504	293	195	117	79.80	71.50	105	157	135	118	101	130	133	135
Inventory Turnover	2.00	1.10	0.70	1.20	1.90	3.10	4.60	5.10	3.50	2.30	0.70	0.80	0.90	0.70	0.70	0.70

Debt to Revenue	--	--	--	--	--	--	--	--	--	0.41	1.47	--	1.63	1.64	1.42	1.47
COGS to Revenue	0.27	0.20	0.23	0.24	0.26	0.25	0.29	0.30	0.32	0.32	0.36	0.31	0.31	0.32	0.33	0.36
Inventory to Revenue	0.13	0.19	0.32	0.20	0.14	0.08	0.06	0.06	0.09	0.14	0.54	0.40	0.35	0.46	0.48	0.54
Interest Exp. to Revenue %	1.64	1.47	2.89	3.42	4.14	--	--	--	--	-1.43	-2.36	--	-0.58	-2.64	-2.27	-2.36

Asset Turnover	0.51	0.69	0.72	0.67	0.71	0.90	1.08	0.92	0.70	0.58	0.14	0.19	0.15	0.14	0.16	0.14
Buyback Ratio	590	-80.70	88.00	-37.60	51.10	65.20	2.40	-3.20	-5.30	-44.80	256	-51.20	-45.00	-125	-6.50	256
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	85.59	144	150	214	258	348	404	438	485	559	588	127	136	137	159	156
Cost of Goods Sold	22.75	29.12	34.76	51.81	66.50	88.36	118	129	157	177	195	38.66	42.68	43.77	52.23	56.71
Gross Profit	62.84	115	115	162	191	260	286	308	328	381	392	87.95	93.02	93.02	107	99.04

Selling, General, &Admin. Expense	45.08	50.28	63.05	88.27	142	165	194	159	160	172	192	43.19	40.47	43.40	44.70	63.48
Research &Development	35.91	49.29	64.39	63.54	77.26	106	118	85.24	110	126	152	32.78	32.96	34.54	26.15	58.20
Earnings Before DDA	-16.67	17.44	-11.02	10.64	-27.54	-7.78	-19.58	70.54	64.30	90.34	59.76	13.67	21.59	16.80	38.28	-16.91

Depreciation, Depletion and Amortization	1.48	1.87	0.98	0.31	0.49	3.05	5.77	6.12	6.23	7.27	11.31	1.69	2.00	1.72	1.87	5.73

Operating Income	-18.15	15.56	-12.00	10.34	-28.03	-10.82	-25.35	64.42	58.07	83.07	48.45	11.98	19.59	15.09	36.41	-22.64
Interest Income/Expense	1.40	2.13	4.34	7.32	10.65	--	--	--	--	-8.01	-11.68	--	-0.78	-3.61	-3.62	-3.67
Net Income	-16.87	17.00	-7.75	63.73	-18.27	-8.50	-76.23	105	128	51.25	32.11	7.57	13.76	9.27	20.66	-11.57

Earnings per Share ($)	-0.37	0.34	-0.16	1.25	-0.35	-0.16	-1.46	1.97	2.35	0.93	0.59	0.14	0.25	0.17	0.38	-0.21
Total Shares Outstanding	45.62	49.77	49.44	51.03	51.62	51.90	52.27	53.18	54.41	55.35	54.05	55.67	55.56	55.15	55.02	54.05
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	136	160	140	197	222	216	176	247	341	570	252	296	517	545	570	252
Accounts Receivable	16.65	19.30	15.53	22.92	27.18	34.99	30.71	47.83	74.93	86.24	90.59	67.89	65.96	83.84	86.24	90.59
Inventory	11.46	27.34	47.99	41.63	35.47	28.23	25.84	25.34	45.15	76.36	84.27	49.97	47.20	62.34	76.36	84.27
Other Current Assets	0.98	1.25	0.97	12.96	7.42	16.40	9.98	4.80	21.13	23.46	32.71	21.60	21.80	21.05	23.46	32.71
Total Current Assets	165	208	205	274	292	296	243	325	482	756	460	435	652	713	756	460

Property, Plant and Equipment	1.51	1.68	3.99	3.07	3.25	27.33	25.07	20.66	17.98	16.10	22.67	17.40	16.92	16.54	16.10	22.67
Intangible Assets	--	--	--	--	14.93	16.35	99.61	97.60	102	134	603	138	137	135	134	603
Other Long Term Assets	0.20	0.16	0.14	41.17	51.15	47.89	7.37	31.25	90.95	65.46	19.42	88.89	92.00	89.05	65.46	19.42
Total Assets	167	210	209	319	362	387	375	474	693	972	1,105	679	898	954	972	1,105

Accounts Payable	25.23	34.86	34.67	45.80	83.62	79.77	85.52	84.84	154	133	115	125	114	141	133	115
Current Portion of Long-Term Debt	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Other Current Liabilities	--	--	--	--	--	9.61	1.10	0.53	0.67	2.38	1.22	0.69	2.05	1.83	2.38	1.22
Total Current Liabilities	25.23	34.86	34.67	45.80	83.62	89.38	86.62	85.37	155	135	116	125	116	143	135	116

Long-Term Debt	--	--	--	--	--	--	--	--	--	226	229	--	221	224	226	229
Other Long-Term Liabilities	1.27	3.52	3.14	2.81	--	--	47.77	31.16	26.37	24.56	148	26.98	27.60	28.71	24.56	148
Total Liabilities	26.50	38.37	37.81	48.62	83.62	89.38	134	117	181	386	492	152	365	395	386	492

Common Stock	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.06	0.06	0.06	0.06	0.06	0.06	0.06
Retained Earnings	-314	-297	-305	-241	-259	-268	-344	-240	-112	-60.41	-71.98	-104	-90.34	-81.07	-60.41	-71.98
Additional Paid-In Capital	455	469	476	511	537	565	585	597	624	697	735	631	674	690	697	735
Treasury Stock	--	--	--	--	--	--	--	--	--	-50.00	-50.00	--	-50.00	-50.00	-50.00	-50.00
Total Equity	140	172	171	270	278	298	240	358	512	586	612	527	533	559	586	612
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	-16.87	17.00	-7.75	63.73	-18.27	-8.50	-76.23	105	128	51.17	31.99	7.57	13.75	9.26	20.58	-11.61
Depreciation, Depletion and Amortization	1.48	1.87	0.98	0.31	0.49	3.05	5.77	6.12	6.23	7.27	11.31	1.69	2.00	1.72	1.87	5.73
Cash Flow from Others	10.15	-5.54	-17.03	-31.91	53.88	43.54	71.41	-43.29	-37.73	-12.09	-29.88	-24.31	5.34	3.67	3.20	-42.09
Cash Flow from Operations	-5.24	13.33	-23.81	32.12	36.10	38.08	0.95	67.47	96.38	46.35	13.43	-15.05	21.10	14.65	25.65	-47.97

Investment for Property, Plant & Equipement	-1.21	-0.80	-3.31	-0.79	-16.50	-21.40	-0.34	-0.34	-8.27	-37.68	-1.86	-36.68	-0.49	-0.21	-0.31	-0.85
Cash Flow from Acquisitions	--	--	--	--	--	-23.53	-37.17	0.26	--	--	-302	--	--	--	--	-302
Cash Flow from Investing	-87.68	-33.98	6.22	-6.30	-32.90	-50.25	-11.22	-18.40	78.41	-63.51	-290	-49.83	-25.65	0.43	11.54	-276

Net Issuance of Stock	99.54	13.73	6.83	23.97	9.33	5.54	1.80	3.36	6.73	-27.07	-1.21	3.88	-43.81	11.53	1.33	29.74
Net Issuance of Debt	--	--	--	--	--	--	--	--	--	217	217	--	217	--	--	--
Other Financing	--	--	--	--	--	--	--	--	9.39	31.21	34.49	0.37	29.52	0.81	0.51	3.65
Cash Flow from Financing	99.54	13.73	6.83	23.97	9.33	5.54	1.80	3.36	16.12	221	250	4.25	202	12.35	1.84	33.38

Net Change in Cash	6.63	-6.90	-10.80	49.82	12.60	-7.11	-8.79	54.14	189	204	-27.14	-59.86	197	28.05	39.06	-291

Free Cash Flow	-6.45	12.53	-27.12	31.33	19.60	16.68	0.61	67.13	88.11	8.66	11.57	-51.73	20.61	14.44	25.34	-48.82
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

MDCO Quarterly/Annuals Reports

MDCO: 10-Q - MEDICINES CO /DE (0001113481) (Filer): (10-Q) - 2012-11-09
MDCO: 10-K/A - MEDICINES CO /DE (0001113481) (Filer): (10-K/A) - 2012-06-05
MDCO: 10-Q - MEDICINES CO /DE (0001113481) (Filer): (10-Q) - 2012-05-10
MDCO: 10-K - MEDICINES CO /DE (0001113481) (Filer): (10-K) - 2012-02-29
MDCO: 10-K/A - MEDICINES CO /DE (0001113481) (Filer): (10-K/A) - 2011-05-24

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

MDCO Quarterly/Annuals Reports